在职成人输尿管镜术后脓毒症患病率及相应急诊入院与死亡率
基于IBM MarketScan商业数据库的回顾性分析纳入2015至2019年接受输尿管镜的18-64岁在职成人109 496例,5.6%发生脓毒症(非重症4.1%、重症1.5%)。脓毒症增加30天住院死亡、ICU入住、住院和再入院风险;研究期间脓毒症患病率从4.7%升至6.6%,相关死亡率从0.7%降至0.2%。
要点
- 109 496例输尿管镜患者中5.6%发生脓毒症,重症脓毒症占1.5%。
- 30天住院死亡率:对照组0.03%、非重症脓毒症0.3%、重症脓毒症2.5%(P < 0.001)。
- 研究期间脓毒症患病率由4.7%升至6.6%,相关死亡率由0.7%降至0.2%(均P < 0.001)。
核心结论
- 在18-64岁在职成人中,输尿管镜术后脓毒症增加30天住院死亡、ICU入住、住院和再入院风险。
- 输尿管镜术后脓毒症患病率随时间上升,但相关死亡率下降。
- 泌尿外科医生应意识到输尿管镜术后脓毒症在年轻患者中可能致命。
研究设计与样本
- 回顾性分析IBM MarketScan商业数据库,纳入2015至2019年接受输尿管镜的18-64岁在职成人109 496例。
- 患者按输尿管镜术后30天内分为无脓毒症(对照组)、非重症脓毒症和重症脓毒症。
主要发现
- 109 496例中5.6%发生脓毒症,其中非重症4.1%、重症1.5%。
- 30天住院死亡率分别为对照组0.03%、非重症脓毒症0.3%、重症脓毒症2.5%(P < 0.001)。
- 多变量分析中,脓毒症(不论严重程度)较无脓毒症增加30天住院死亡风险(HR 17.2,95%CI 10.5-28.1;P < 0.001),重症脓毒症HR 49.5(95%CI 28.9-84.7;P < 0.001)。
- 手术当日ICU入住率分别为对照组1.5%、非重症脓毒症19.8%、重症脓毒症52.4%,住院率分别为18.3%、74.9%、76.9%,再入院率分别为7.1%、12.0%、15.9%(均P < 0.001)。
- 研究期间输尿管镜术后脓毒症患病率从4.7%升至6.6%(P < 0.001),相关死亡率从0.7%降至0.2%(P < 0.001)。
临床怎么用
- 作者结论指出,泌尿外科医生应意识到输尿管镜术后脓毒症在年轻患者中可能致命。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine 30-day inpatient mortality, intensive care unit (ICU) admissions, inpatient admissions/readmissions, and yearly trends in sepsis prevalence and inpatient mortality after ureteroscopy (URS) in employed adults. MATERIALS AND METHODS: We performed a retrospective analysis of the IBM MarketScan Commercial Database to identify employed adults aged 18-64 years who underwent URS between 2015 and 2019. Patients were categorized as having no sepsis (controls), non-severe sepsis, or severe sepsis within 30 days of URS. The main outcomes included inpatient mortality, ICU admissions, inpatient admissions, readmissions, and annual rates of sepsis and associated inpatient mortality. RESULTS: Among 109 496 patients undergoing URS, 5.6% developed sepsis (4.1% non-severe, 1.5% severe). The 30-day inpatient mortality rates were 0.03%, 0.3% and 2.5% for controls, non-severe sepsis and severe sepsis, respectively (P < 0.001). In a multivariable analysis, diagnosis of sepsis regardless of severity (hazard ratio [HR] 17.2, 95% confidence interval [CI] 10.5-28.1; P < 0.001) or severe sepsis (HR 49.5, 95% CI 28.9-84.7; P < 0.001) increased the risk of 30-day inpatient mortality compared to no sepsis (controls). ICU admissions on the day of procedure (1.5%, 19.8% and 52.4%), inpatient admission rates (18.3%, 74.9% and 76.9%) and readmission rates (7.1%, 12.0% and 15.9%) were higher with severe sepsis and non-severe sepsis vs controls (all P < 0.001). During the study period, the prevalence of sepsis after URS increased from 4.7% to 6.6% (P < 0.001), while the associated mortality rate decreased from 0.7% to 0.2% (P < 0.001). CONCLUSION: Among working adults aged 18-64 years, sepsis after URS increases the risk of 30-day inpatient mortality, ICU and hospital admission, and hospital readmission. Although the prevalence of sepsis after URS is increasing over time, associated mortality rates are declining. Urologists should be aware of the potentially deadly consequences of sepsis after URS in younger patients.
引用
- Bhojani N, Eisner B, Monga M, et al. Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults. BJU Int. 2023. PMID: 37057736. doi:10.1111/bju.16029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。